Monocyte CD163 is altered in association with diabetic complications: possible protective role

Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study

(2015) Stijn A Peeters et al.   Cardiovascular Diabetology

Overexpression of CD163 in vitreous and fibrovascular membranes of patients with proliferative diabetic retinopathy: possible involvement of periostin

(2014) Yoshiyuki Kobayashi et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Soluble CD163 levels are elevated in cerebrospinal fluid and serum in people with Type 2 diabetes mellitus and are associated with impaired peripheral nerve function

(2014) M. Kallestrup et al.   DIABETIC MEDICINE

Elevated Soluble CD163 in Gestational Diabetes Mellitus: Secretion from Human Placenta and Adipose Tissue

(2014) Muhammad Furqan Bari et al.   PLoS One

Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus

(2013) Andrew E. Hogan et al.   DIABETOLOGIA

The Macrophage-Specific Serum Marker, Soluble CD163, Is Increased in Obesity and Reduced After Dietary-Induced Weight Loss

(2013) Karen Fjeldborg et al.   Obesity

Soluble CD163: a biomarker linking macrophages and insulin resistance

(2012) T. Parkner et al.   DIABETOLOGIA

Alterations in Monocyte CD16 in Association with Diabetes Complications

(2012) Danqing Min et al.   MEDIATORS OF INFLAMMATION

Monocyte subpopulations and cardiovascular risk in chronic kidney disease

(2012) Gunnar H. Heine et al.   Nature Reviews Nephrology

CD14 dim CD16 + and CD14 + CD16 + Monocytes in Obesity and During Weight Loss

(2011) Christine Poitou et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Protection From Retinopathy and Other Complications in Patients With Type 1 Diabetes of Extreme Duration: The Joslin 50-Year Medalist Study

(2011) J. K. Sun et al.   DIABETES CARE

In vitro and in vivo evidence for the role of elastase shedding of CD163 in human atherothrombosis

(2011) Juan Antonio Moreno et al.   EUROPEAN HEART JOURNAL

CD163 and its role in inflammation

(2011) Krzysztof Kowal et al.   FOLIA HISTOCHEMICA ET CYTOBIOLOGICA

Differential Expression of CD163 on Monocyte Subsets in Healthy and HIV-1 Infected Individuals

(2011) Emma Tippett et al.   PLoS One

Glucocorticoid treatment skews human monocyte differentiation into a hemoglobin-clearance phenotype with enhanced heme-iron recycling and antioxidant capacity

(2010) F. Vallelian et al.   BLOOD

New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis

(2010) S. Gaïni et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Serum Soluble CD163 Predicts Risk of Type 2 Diabetes in the General Population

(2010) H. J. Moller et al.   CLINICAL CHEMISTRY

Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects

(2010) M. R. Dasu et al.   DIABETES CARE

Macrophages and Diabetic Nephropathy

(2010) Greg H. Tesch   SEMINARS IN NEPHROLOGY